Lexicon Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business UpdateGlobeNewsWire • 11/08/23
Lexicon Pharmaceuticals to Host Third Quarter 2023 Financial Results Conference Call and Webcast on November 8, 2023GlobeNewsWire • 11/03/23
Data on Early Clinical Benefit for INPEFA® (Sotagliflozin) Will Be Among Five Lexicon-Sponsored Presentations at the American Heart Association Scientific Sessions 2023GlobeNewsWire • 11/02/23
INPEFA® (Sotagliflozin) Receives Coverage From Express Scripts on Its Basic and High Performance Formularies for Commercially Insured PatientsGlobeNewsWire • 11/01/23
New Data Relating to Sotagliflozin to be Presented at the American Society of Nephrology (ASN) Kidney Week 2023 Annual MeetingGlobeNewsWire • 10/30/23
Data From Two Studies Demonstrating Positive Financial Impact of INPEFA® (Sotagliflozin) to be Presented at the Academy of Managed Care Pharmacy (AMCP) Nexus 2023 National MeetingGlobeNewsWire • 10/17/23
Data Demonstrating Financial Impact of INPEFA® (Sotagliflozin) to be Presented at the Academy of Managed Care Pharmacy (AMCP) Nexus 2023 National MeetingGlobeNewsWire • 10/11/23
Lexicon Pharmaceuticals shares rise on Express Scripts support for Inpefa heart drugProactive Investors • 10/10/23
INPEFA® (Sotagliflozin) Receives Preferred Formulary Status With Express Scripts For Medicare PatientsGlobeNewsWire • 10/09/23
Tom Garner Joins Lexicon as Senior Vice President and Chief Commercial OfficerGlobeNewsWire • 10/09/23
Lexicon to Present Post Hoc Analysis of Scored Clinical Trial at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2023GlobeNewsWire • 09/28/23
Lexicon Pharmaceuticals to Participate in the H.C. Wainwright & Co. 25th Annual Global Investment ConferenceGlobeNewsWire • 09/07/23
Lexicon Announces Series of Presentations Relating to LX9211, Its Investigational Drug for the Treatment of Diabetic Peripheral Neuropathic Pain (DPNP)GlobeNewsWire • 09/07/23
Lexicon to Present Analyses of INPEFA™ (sotagliflozin) Clinical Study Results and Changing Patterns of Heart Failure Diagnoses at the European Society of Cardiology (ESC) Congress 2023GlobeNewsWire • 08/21/23
Published Analysis of Sotagliflozin (INPEFA(TM)) Clinical Data Demonstrates Significant Reductions in the Risk of Hospital Readmissions for Heart FailureGlobeNewsWire • 08/08/23
Lexicon Pharmaceuticals (LXRX) Reports Q2 Loss, Tops Revenue EstimatesZacks Investment Research • 08/03/23
Lexicon Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business UpdateGlobeNewsWire • 08/03/23
Lexicon Pharmaceuticals to Host Second Quarter 2023 Financial Results Conference Call and Webcast on August 3, 2023GlobeNewsWire • 07/28/23